Evidence map›Paper›PMID 30069311›Full record

ArticleJournal of thoracic disease2018

Radiopaque preventive landmarks' placement during stentless bioprosthesis implantation.

Niki Lama, Vasileios Patris, Dimitrios Fagkrezos, Petros Moschouris, Konstantinos Giakoumidakis, Charikleia Triantopoulou, Petros Maniatis, Mihalis Argiriou

Abstract read
In one paragraph

Article in Journal of thoracic disease, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Niki LamaDepartment of Computed Tomography, "Konstantopouleio" General Hospital of Athens, Athens, Greece.
Vasileios PatrisDepartment of Cardiac Surgery, "Evangelismos" General Hospital of Athens, Athens, Greece.
Dimitrios FagkrezosDepartment of Radiology, "Konstantopouleio" General Hospital of Athens, Athens, Greece.
Petros MoschourisDepartment of Computed Tomography, "Konstantopouleio" General Hospital of Athens, Athens, Greece.
Konstantinos GiakoumidakisDepartment of Cardiac Surgery, "Evangelismos" General Hospital of Athens, Athens, Greece.
Charikleia TriantopoulouDepartment of Radiology, "Konstantopouleio" General Hospital of Athens, Athens, Greece.
Petros ManiatisDepartment of Computed Tomography, "Konstantopouleio" General Hospital of Athens, Athens, Greece.
Mihalis ArgiriouDepartment of Cardiac Surgery, "Evangelismos" General Hospital of Athens, Athens, Greece.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundIn patients with aortic stenosis, bioprosthetic valves are increasingly used. Although their benefits, they are also presenting limitations, as their time-related degeneration. Reoperation which was, until a few years ago, the only treatment for this condition, carries a significant surgical risk, especially in patients with multiple comorbidities, so the benefit of less invasive technique enabling the implantation of aortic valve prosthesis [transcatheter aortic valve-in-surgical aortic valve (TAV-in-SAV)] by a percutaneous access is remarkably important. Eligible patients are judged by a heart team, and imaging plays a key role in this selection, focusing on correct identification of bioprosthetic aortic valves type and size, evaluation of patients at increased anatomical risk for coronary artery occlusion. Radiolucency of stentless bioprosthetic valves, represent a significant challenge.

methodsSurgical aortic valve replacements (SAVRs) with a bioprosthesis were performed using a stentless valve with no radiopaque components (Solo Smart, Sorin). The chosen method, in order to evaluate the results of the operation, was computed tomography (CT) scanning (64-slice MDCT, Brilliance, Philips). The study consisted of a thin sliced contrast electrocardiograph (ECG) gated chest CT (1 systolic cardiac phase), trying to simulate the required assessment of aortic root and the radiopaque placed markers.

resultsAs surgical implant technique varies and may impact the relationship of the prosthetic annulus to the coronary ostia, marking the aortic annulus during the operation in order to have some useful radiopaque landmarks, is a great assistance promoting better orientation and correct identification of the position of the bioprosthetic valve. Although the implantation of metallic vascular clips at the level of aortic annulus (in any commissure or in the middle of any cups) was considered, the decision was to position three metallic clips bellow the aortic annulus in the three stiches ligated during the solo valve implantation.

conclusionsWe are suggesting the preventive implantation of radiopaque landmarks, during SAVRs using tissue valves which are lacking fixed anatomic markers, as a guide for a presumptive TAV-in-SAV procedure, keeping in mind that appropriate guidance is crucial and can prevent valve misplacement, coronary obstruction and other potentially lethal complications.

Indexed as

Landmarksradiopaquetranscatheter aortic valve-in-surgical aortic valve (TAV-in-SAV)

Identifiers

PMID30069311
PMCPMC6051846

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.